The effects of radioiodine therapy on peripheral blood lymphocyte subpopulations in patients with Graves' disease. Preliminary report

Nuclear Medicine Review

Volumn 5, Issue 1, 2002, Pages 35-38

  Turowska, Magdalena D ^a   Turowski, Dariusz ^a   Wysocka, Jolanta ^a   Rogowski, Franciszek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

131I; Graves' disease; Lymphocytes

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; IODINE 131; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DISEASE EXACERBATION; EXOPHTHALMOS; EYE DISEASE; GRAVES DISEASE; HELPER CELL; HUMAN; IMMUNE RESPONSE; LACRIMATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; ORBIT DISEASE; PERIPHERAL LYMPHOCYTE; PREDICTION; RADIATION INJURY; REMISSION; SUPPRESSOR CELL; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

EID: 0036299618     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Thyroid autoimmunity
2. T-cell subsets (Th1 versus Th2)
3. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes
4. Peripheral blood T cell activation after radioiodine treatment for Graves' disease
5. Analysis of orbital T cells in thyroid-associated ophthalmopathy
6. Radioiodine and the immune system
7. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy
8. Radioiodine treatment, ablation and ophthalmopathy: A balanced perspective
9. Chronology of Graves' op-hthalmopathy in an incidence cohort
10. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy
11. Radioiodine therapy for Graves' disease: Case selection and restrictions recommended to patients in North America
12. Dosage determination with radioactive isotopes
13. Effects of radioactive iodine therapy on cytokine production in Graves' disease: Transient increases in IL-4, IL-6, IL-10, and tumor necrosis factor-a, with longer term increases in interferon-γ production
14. The incidence of ophtalmopathy after radioiodine therapy for Graves' disease: Prognostic factors and the role of methimazole
15. Prospective and controlled study of ophtalmopathy after radioiodine therapy for Graves' hyperthyroidism
16. Relation between therapy for hyperthyroidism and the course of Graves' ophtalmopathy
17. + T cells at the retrobulbar space of patients with thyroid-associated ophtalmopathy